Online BusinessGovt hints nexus between private, state-owned vaccine units
Hinting that a nexus between private and state-owned vaccine companies could have led to gradual decline in production capacity of state-owned units, the government today said the matter required in depth probe.
- Fakes make up 20-25% of Rs 85,000 cr pharma sales - Dr Reddy"s Q1 net zooms 120% at Rs 244 cr - Ranbaxy gets nod to sell Ran-Simvastatin tablets in Canada - Zandu Pharma Q1 profit doubles at Rs 11.12 cr - Ranbaxy gets Canada"s nod to mkt anti-hypertension drug - Teva Pharma recalls anti-anxiety drug Propofol
"Till recently the production of the three government units was 80 per cent and then it came down to just around 10 per cent. There is something wrong. I smell a nexus between these units and private sector," Health Minister Ghulam Nabi Azad said in the Rajya Sabha.
Replying to supplementaries during Question Hour, he pointed out that prices of vaccines produced in private units were shooting up.
"I can"t say it was done (decline in production in government units) to help private units. But it could be a possibility. This needs an in depth probe and an external agency needs to look into it," he said.
He said manufacturing licenses of three state-owned vaccine institutes namely Central Research Institute (Kasauli), Pasteur Institute of India in Coonoor (Tamil Nadu), and BCG Vaccine Laboratory in Chennai were suspended in January 2008.
This was done as the units were not found in compliance with the Good Manufacturing Practices (GMP) as provided under Schedule M of Drugs and Cosmetics Rules 1945, he said.
CRI (Kasauli) was established in 1905, PII (Coonoor) in 1907 and the Chennai unit in 1948.